133 related articles for article (PubMed ID: 30459061)
1. Racial and Ethnic Disparities in Renal Cell Carcinoma: An Analysis of Clinical Characteristics.
Batai K; Harb-De la Rosa A; Lwin A; Chaus F; Gachupin FC; Price E; Lee BR
Clin Genitourin Cancer; 2019 Feb; 17(1):e195-e202. PubMed ID: 30459061
[TBL] [Abstract][Full Text] [Related]
2. Racial/ethnic disparities in renal cell carcinoma: Increased risk of early-onset and variation in histologic subtypes.
Batai K; Harb-De la Rosa A; Zeng J; Chipollini JJ; Gachupin FC; Lee BR
Cancer Med; 2019 Nov; 8(15):6780-6788. PubMed ID: 31509346
[TBL] [Abstract][Full Text] [Related]
3. Late recurrence of renal cell carcinoma >5 years after surgery: clinicopathological characteristics and prognosis.
Park YH; Baik KD; Lee YJ; Ku JH; Kim HH; Kwak C
BJU Int; 2012 Dec; 110(11 Pt B):E553-8. PubMed ID: 22578274
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous radiofrequency ablation for renal cell carcinoma vs. partial nephrectomy: Comparison of long-term oncologic outcomes in both clear cell and non-clear cell of the most common subtype.
Liu N; Huang D; Cheng X; Chong Y; Wang W; Gan W; Guo H
Urol Oncol; 2017 Aug; 35(8):530.e1-530.e6. PubMed ID: 28408296
[TBL] [Abstract][Full Text] [Related]
5. Histologic subtype needs to be considered after partial nephrectomy in patients with pathologic T1a renal cell carcinoma: papillary vs. clear cell renal cell carcinoma.
Yoo S; You D; Jeong IG; Song C; Hong B; Hong JH; Ahn H; Kim CS
J Cancer Res Clin Oncol; 2017 Sep; 143(9):1845-1851. PubMed ID: 28451753
[TBL] [Abstract][Full Text] [Related]
6. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive Analysis of Survival Outcomes in Non-Clear Cell Renal Cell Carcinoma Patients Treated in Clinical Trials.
de Velasco G; McKay RR; Lin X; Moreira RB; Simantov R; Choueiri TK
Clin Genitourin Cancer; 2017 Dec; 15(6):652-660.e1. PubMed ID: 28410911
[TBL] [Abstract][Full Text] [Related]
8. Comparison of type I and II papillary renal cell carcinoma (RCC) and clear cell RCC.
Waldert M; Haitel A; Marberger M; Katzenbeisser D; Ozsoy M; Stadler E; Remzi M
BJU Int; 2008 Nov; 102(10):1381-4. PubMed ID: 18782311
[TBL] [Abstract][Full Text] [Related]
9. Three-dimensional tumour volume and cancer-specific survival for patients undergoing nephrectomy to treat pT1 clear-cell renal cell carcinoma.
Jorns J; Thiel DD; Lohse CM; Williams A; Arnold ML; Cheville JC; Leibovich BC; Parker AS
BJU Int; 2012 Oct; 110(7):956-60. PubMed ID: 22300498
[TBL] [Abstract][Full Text] [Related]
10. Does chromophobe renal cell carcinoma have better survival than clear cell renal cell carcinoma? A clinical-based cohort study and meta-analysis.
Jiang HM; Wei JH; Zhang ZL; Fang Y; Zhou BF; Chen ZH; Lu J; Liao B; Zhou FJ; Luo JH; Chen W
Int Urol Nephrol; 2016 Feb; 48(2):191-9. PubMed ID: 26589610
[TBL] [Abstract][Full Text] [Related]
11. The Effect of Patient and Surgical Characteristics on Renal Function After Partial Nephrectomy.
Winer AG; Zabor EC; Vacchio MJ; Hakimi AA; Russo P; Coleman JA; Jaimes EA
Clin Genitourin Cancer; 2018 Jun; 16(3):191-196. PubMed ID: 29325738
[TBL] [Abstract][Full Text] [Related]
12. Microvascular and lymphovascular tumour invasion are associated with poor prognosis and metastatic spread in renal cell carcinoma: a validation study in clinical practice.
Bedke J; Heide J; Ribback S; Rausch S; de Martino M; Scharpf M; Haitel A; Zimmermann U; Pechoel M; Alkhayyat H; Shariat SF; Dombrowski F; Stenzl A; Burchardt M; Klatte T; Kroeger N
BJU Int; 2018 Jan; 121(1):84-92. PubMed ID: 28803448
[TBL] [Abstract][Full Text] [Related]
13. Racial Disparities and Preventive Measures to Renal Cell Carcinoma.
Sims JN; Yedjou CG; Abugri D; Payton M; Turner T; Miele L; Tchounwou PB
Int J Environ Res Public Health; 2018 May; 15(6):. PubMed ID: 29843394
[TBL] [Abstract][Full Text] [Related]
14. Pathologic and clinical characteristics of early onset renal cell carcinoma.
Clemmensen T; Matoso A; Graham T; Lai WS; Rais-Bahrami S; Gordetsky J
Hum Pathol; 2018 Apr; 74():25-31. PubMed ID: 29133143
[TBL] [Abstract][Full Text] [Related]
15. Comparison of presentation and outcome for patients 18 to 40 and 60 to 70 years old with solid renal masses.
Gillett MD; Cheville JC; Karnes RJ; Lohse CM; Kwon ED; Leibovich BC; Zincke H; Blute ML
J Urol; 2005 Jun; 173(6):1893-6. PubMed ID: 15879770
[TBL] [Abstract][Full Text] [Related]
16. Contemporary management of renal cell carcinoma (RCC) in Victoria: implications for longer term outcomes and costs.
Ta AD; Bolton DM; Dimech MK; White V; Davis ID; Coory M; Millar J; Giles G
BJU Int; 2013 Nov; 112 Suppl 2():36-43. PubMed ID: 24127675
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of extensive necrosis in renal cell carcinoma.
Collins J; Epstein JI
Hum Pathol; 2017 Aug; 66():108-114. PubMed ID: 28669641
[TBL] [Abstract][Full Text] [Related]
18. Racial and ethnic disparities in the diagnosis of breast cancer: changes in presenting stage in minority populations in Florida during 1981-2009.
Dosch AR; Koru-Sengul T; Miao F; Tannenbaum SL; Byrne MM; Wright JL
Breast Cancer Res Treat; 2014 Nov; 148(2):379-87. PubMed ID: 25301087
[TBL] [Abstract][Full Text] [Related]
19. Long-Term Outcomes of Patients With Low Grade Cystic Renal Epithelial Neoplasms.
Westerman ME; Cheville JC; Lohse CM; Sharma V; Boorjian SA; Leibovich BC; Thompson RH
Urology; 2019 Nov; 133():145-150. PubMed ID: 31356826
[TBL] [Abstract][Full Text] [Related]
20. Age at diagnosis and the surgical management of small renal carcinomas: findings from a cross-sectional population-based study.
White VM; Marco DJT; Bolton D; Papa N; Neale RE; Coory M; Davis ID; Wood S; Giles GG; Jordan SJ
BJU Int; 2018 Nov; 122 Suppl 5():50-61. PubMed ID: 30307688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
